Drugs / Tongren-Dahuoluo Bolus
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT06674759 | Jan → Jun 2025 overdue | osteoarthritis, knee | Guang'anmen Hospital of China Academy of Chinese Medical Sciences | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Tongren-Dahuoluo Bolus | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06674759 ↗ |
| Route | Oral | “0.72g,2 times a day, oral, for 24 weeks.” NCT06674759 ↗ |